Incremental Mortality Associated with Nontuberculous Mycobacterial Lung Disease Among US Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease

被引：0
|
作者：
Wang, P. [1 ]
Marras, T. K. [2 ,3 ]
Alemao, E. [1 ]
Hassan, M. [1 ]
Chatterjee, A. [1 ]
机构：
[1] Insmed Inc, Bridgewater, NJ USA
[2] Univ Toronto, Med, Toronto, ON, Canada
[3] Toronto Western Hosp, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1192
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PREDICTORS OF NEBULIZED ARFORMOTEROL USE: A RETROSPECTIVE ANALYSIS AMONG MEDICARE BENEFICIARIES WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Gilmer, T. P.
    Ganapathy, V
    Xu, Z.
    Celli, B. R.
    Sharma, G.
    Cho-Reyes, S.
    Navaie, M.
    VALUE IN HEALTH, 2017, 20 (05) : A206 - A207
  • [42] Cellular Characterization of Chronic Nontuberculous Mycobacterial Lung Disease
    Chan, E. D.
    Ordway, D.
    Bai, X.
    Garcia, C.
    Koelsch, T.
    Mitchell, J.
    Schenkel, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [43] Pulmonary Rehabilitation and Readmission Rates for Medicare Beneficiaries with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Myers, L.
    Faridi, M. K.
    Camargo, C. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [44] Pulmonary Rehabilitation and Readmission Rates for Medicare Beneficiaries with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Myers, Laura C.
    Faridi, Mohammad Kamal
    Hasegawa, Kohei
    Camargo, Carlos A., Jr.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (04): : 427 - 440
  • [45] The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
    Wang, Ping-Huai
    Pan, Sheng-Wei
    Wang, Su-Mei
    Shu, Chin-Chung
    Chang, Chin-Hao
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [46] BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease
    Kim, Hyung-Jun
    Kwak, Nakwon
    Hong, Hyunsook
    Kang, Noeul
    Im, Yunjoo
    Jhun, Byung Woo
    Yim, Jae-Joon
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (02) : 230 - 236
  • [47] Impact of Maintenance Therapy on Hospitalization and Expenditures for Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease
    Stuart, Bruce C.
    Simoni-Wastila, Linda
    Zuckerman, Ilene H.
    Davidoff, Amy
    Shaffer, Thomas
    Yang, Hui-wen Keri
    Qian, Jingjing
    Dalal, Anand A.
    Mapel, Douglas W.
    Bryant-Comstock, Lynda
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (05): : 441 - 453
  • [48] The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease
    Zhang, Xiangjun
    Sim, Yongbo
    Tsang, Chi Chun Steve
    Wang, Junling
    Finch, Christopher K.
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2024, 15
  • [49] Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease
    Jhun, Byung Woo
    Jung, Woo Jin
    Hwang, Na Young
    Park, Hye Yun
    Jeon, Kyeongman
    Kang, Eun-Suk
    Koh, Won-Jung
    PLOS ONE, 2017, 12 (11):
  • [50] Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease
    Kim, Bo-Guen
    Shin, Sun Hye
    Lee, Sun-Kyung
    Kim, Sang-Heon
    Lee, Hyun
    RESPIRATORY RESEARCH, 2024, 25 (01)
12345